Fidelity Advert
Shehu Sani

The controversy surrounding the Kaduna Central senatorial slot, ahead of 2019 general elections, Alhaji Uba Sani has been issued with the certificate of return.

Uba Sani gets Kaduna central senatorial ticket

Sani was among those given the certificates on Monday by Mr. Mathew Idouriyekemwen, the Chairman of the electoral committee set up by the National Working Committee (NWC) of the All Progressive Congress (APC) to conduct primaries in Kaduna State.

The Certificates of Return were given to the elected senatorial candidates from the three zones.

The certificate of return was given to Uba Sani despite the insistence of the incumbent senator, Sen. Shehu Sani, that he was given an automatic ticket by the party’s NWC, ChannelsTVreports.

With the issuance of the certificates, the senatorial candidates in are Uba Sani for Kaduna central, Suleiman Abdu-Kwari for Kaduna North and Bala Bantex for Kaduna south.

Uba Sani is said to be the preferred candidate of Governor Nasir El-Rufai of Kaduna state.

The committee also presented certificates to winners for the House of Representatives and State Assembly elections.

In his remarks, the electoral committee chairman said the primary was free and fair and has the backing of the party’s national leadership.

Shehu Sani had lost the APC ticket in the primary conducted by delegates from the zone in which he garnered only 15 votes.

Sani had earlier indicated that he would not participate in what he called a “Kangaroo election organised by the Kaduna State Government’’.

The election was conducted at the Murtala Square in Kaduna.

The Returning Officer, Prof. Eddie Floyd-Igbo, declared Uba Sani, a Special Adviser to Gov. Nasiru El-Rufa’i, as the winner with 2,088 votes, while his closest rival, Usman Ibrahim-Sardauna was said to have secured only 129 votes.

Also, a former senator, Gen. Sani Sale, who represented the constituency from 2011 to 2015 secured 55 votes, followed by Shamsudeen Giwa with 6 votes while 45 votes were declared invalid.

 

Via Vanguard

LEAVE A REPLY

Please enter your comment!
Please enter your name here